Measures to reduce mother-to-child transmission of hepatitis B virus in China: A meta-analysis

Digestive Diseases and Sciences

Volumn 59, Issue 2, 2014, Pages 242-258

  Xu, Hua ^a   Zeng, Teng ^a   Liu, Jun Ying ^a,b   Lei, Yu ^a   Zhong, Shan ^a   Sheng, Yun Jian ^a   Zhou, Zhi ^a   Ren, Hong ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Zhoukou Central Hospital   (China)

Author keywords

Hepatitis B virus; Meta analysis; Mother to child transmission; Reduce

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; PLACEBO;

ANTIBODY BLOOD LEVEL; ANTIVIRAL THERAPY; BIRTH; CESAREAN SECTION; CHINA; CHRONIC HEPATITIS; CLINICAL TRIAL (TOPIC); CONTROL GROUP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; INFECTION PREVENTION; INTRAUTERINE INFECTION; META ANALYSIS; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; VAGINAL DELIVERY; VERTICAL TRANSMISSION;

ADULT; ANTIVIRAL AGENTS; CESAREAN SECTION; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULINS; INCIDENCE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ODDS RATIO; PREGNANCY; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896728000     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2918-0     Document Type: Review

References (52)

1. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect. 1996;117:313-325.
2. Tran TT. Management of hepatitis B in pregnancy: weighing the options. Clevel Clin J Med. 2009;76:S25-S29.
3. Kim SS, Cheong JY, Cho SW. Current nucleos(t)ide analogue therapy for chronic hepatitis B. Gut Liver. 2011;5:278-287.
4. Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol. 2012;4:74-80.
5. Degli Esposti S, Shah D. Hepatitis B in pregnancy: challenges and treatment. Gastroenterol Clin North Am. 2011;40:355-372.
6. Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol. 2004;10:437-438.
7. Bai H, Zhang L, Ma L, Dou XG, Feng GH, Zhao GZ. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World J Gastroenterol. 2007;13:3625-3630.
8. Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol. 2002;67:20-26.
9. Yogeswaran K, Fung SK. Chronic hepatitis B in pregnancy: unique challenges and opportunities. Korean J Hepatol. 2011;17:1-8.
10. Yang J, Zeng XM, Men YL, Zhao LS. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus - a systematic review. Virol J. 2008;5:100.
11. Kumar A. Hepatitis B: virus infection and pregnancy: a practical approach. Indian J Gastroenterol. 2012;31:43-54.
12. Deng M, Zhou X, Gao S, et al. The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis. Virol J. 2012;9:185.
13. Li XM, Shi MF, Yang YB, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol. 2004;10:3215-3217.
14. Zhu Q, Yu G, Yu H, et al. A randomized control trial on interruption of HBV transmission in uterus. Chin Med J. 2003;116:685-687.
15. Borgia G, Carleo MA, Gaeta GB, Gentile I. Hepatitis B in pregnancy. World J Gastroenterol. 2012;18:4677-4683.
16. Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol. 2011;17:4321-4333.
17. Lin HH, Kao JH, Hsu HY, Mizokami M, Hirano K, Chen DS. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol. 1996;87:244-248.
18. Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J. 2002;115:1510-1512.
19. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care. 1996;12:195-208.
20. Ryu HJ, Lee JM, Ahn SH, et al. Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B. J Med Virol. 2010;82:1835-1842.
21. Qiu YW, Jiang XH, Huang LH, et al. A study on the treatment of chronic hepatitis B with YMDD mutation. Chin J Hepatol. 2009;17:171-174.
22. Sheng YJ, Liu JY, Tong SW, et al. Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis. Virol J. 2011;8:393.
23. Yuan J, Lin J, Xu A, et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat. 2006;13:597-604.
24. Li XM, Yang YB, Hou HY, et al. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol. 2003;9:1501-1503.
25. Xu Q, Xiao L, Lu XB, Zhang YX, Cai X. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol. 2006;12:3434-3437.
26. Yue Y, Yang X, Zhang S. Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism. Chin Med J. 1999;112:37-39.
27. Zhu Q, Lu Q, Gu X, Xu H, Duan S. A preliminary study on interruption of HBV transmission in uterus. Chin Med J. 1997;110:145-147.
28. Wang FY, Lin P, Zhang HZ. A randomized controlled trial on effect of hepatitis B immune globulin in preventing hepatitis B virus transmission from mothers to infants. Chin J Pediatr. 2008;46:61-63.
29. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16:94-103.
30. Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol. 2011;55:1215-1221.
31. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol. 2004;10:910-912.
32. Pan CQ, Han GR, Jiang HX, et al. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol. 2012;10:520-526.
33. Yu M, Jiang Q, Ji Y, et al. The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus. Eur J Clin Microbiol Infect Dis. 2012;31:2211-2218.
34. Zang L-J, Wang L. Blocking intrauterine infection by telbivudine in pregnant chronic hepatitis B patients. Chin J Hepatol. 2009;17:561-563.
35. Han G-R, Jiang H-X, Wang G-J, et al. Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus. Chin J Hepatol. 2012;20:201-205.
36. Chen H, Ren J, Liu X-H. Influence of different delivery patterns on mother-to-child vertical transmission of HBV. Chin J Woman Child Health Res. 2008;19:214-216.
37. Huang L. Research about the efficacy of delivery mode on maternal-infant transmission of hepatitis B virus. New Med. 2012;43:247-249.
38. Fan W. Effect of delivery mode on maternal-infant transmission of hepatitis B Virus. Guangdong Med J. 2007;28:252-253.
39. Gu J. Effect of delivery mode on maternal-infant transmission of hepatitis B virus. Ningxia Med J. 2006;28:858-859.
40. Zhang Q. Effect of delivery mode on maternal-infant transmission of hepatitis B virus. Chin J Clin Med. 2009;16:570-571.
41. Zhang S. Effect of delivery and interruption mode on maternal-infant transmission of hepatitis B virus. Mod Prev Med. 2006;33:72-74.
42. Cai S. Discuss on relative factors of maternal-infant vertical transmission of hepatitis B virus. Mod Diagn Treat. 2009;20:23-24.
43. Liu H. Relevant research of delivery mode on maternal-infant transmission of hepatitis B virus. Chin J Mod Drug Appl. 2009;3:30-31.
44. Bzowej NH. Optimal management of the hepatitis B patient who desires pregnancy or is pregnant. Curr Hepat Rep. 2012;11:82-89.
45. Yue Y. Clinical study on the prevention of HBV from mother to infant by injection of HBIG in pregnant women with HBsAg. Chin J Pract Gynecol Obstet. 1999;15:547-548.
46. Xiao XM, Li AZ, Chen X, Zhu YK, Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet. 2007;96:167-170.
47. Han ZH, Zhong LH, Wang J, et al. The impact of antepartum injection of hepatitis B immunoglobulin on maternal serum HBV DNA and anti-HBs in the newborns. Chin J Internal Med. 2007;46:376-378.
48. Shi Z, Li X, Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis. 2010;14:e622-e634.
49. Zhang RL, Luo Y, Xie JX, et al. A correlation analysis between the rate of vertical transmission of HBV and HBsAg-positive father to infant and the rate of neonatal cord blood HBV-DNA. Chin J Epidemiol. 2010;31:159-162.
50. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6:1315-1341. quiz 1286.
51. Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a update. Hep Intl. 2008;2008:263-283.
52. Munderi P, Helen Wilkes H, Tumukunde D. Pregnancy rates and outcomes among women on triple-drug antiretroviral therapy in the DART trial [Poster WEPEB261]. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa; 2009.